250 related articles for article (PubMed ID: 25601323)
41. A systematic review of systemic medications for pustular psoriasis in pediatrics.
Posso-De Los Rios CJ; Pope E; Lara-Corrales I
Pediatr Dermatol; 2014; 31(4):430-9. PubMed ID: 24890463
[TBL] [Abstract][Full Text] [Related]
42. The real-world effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for treating moderate-to-severe psoriasis.
Br J Dermatol; 2023 Apr; 188(5):e35. PubMed ID: 37078764
[No Abstract] [Full Text] [Related]
43. A global approach to psoriatic patients through PASI score and Skindex-29.
Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
[TBL] [Abstract][Full Text] [Related]
44. Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series.
Gisondi P; Mattiucci A; Tonin B; Girolomoni G
J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e246-e247. PubMed ID: 30801786
[No Abstract] [Full Text] [Related]
45. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
Feldman SR; Nijsten T; Margolis DJ; Rolstad T
J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096
[No Abstract] [Full Text] [Related]
46. A U.K. multicentre audit of the assessment and management of psoriasis in children.
Lam ML; Burden-Teh E; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Babakinejad P; Murphy R
Br J Dermatol; 2015 Mar; 172(3):789-92. PubMed ID: 25308153
[No Abstract] [Full Text] [Related]
47. Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial.
Fallah Arani S; Neumann H; Hop WC; Thio HB
Br J Dermatol; 2011 Apr; 164(4):855-61. PubMed ID: 21175564
[TBL] [Abstract][Full Text] [Related]
48. [Psoriasis].
Guilhou JJ; Girard C
Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
[No Abstract] [Full Text] [Related]
49. Update on psoriasis therapy: a perspective from the USA.
Koo J; Liao W
Keio J Med; 2000 Mar; 49(1):20-5. PubMed ID: 10750377
[TBL] [Abstract][Full Text] [Related]
50. Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA
G Ital Dermatol Venereol; 2016 Aug; 151(4):432-5. PubMed ID: 25786483
[TBL] [Abstract][Full Text] [Related]
51. The use of cyclosporin in a child with generalized pustular psoriasis.
Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
[No Abstract] [Full Text] [Related]
52. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
Jeffes EW; Weinstein GD
Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
[TBL] [Abstract][Full Text] [Related]
53. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
Janagond AB; Kanwar AJ; Handa S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
[TBL] [Abstract][Full Text] [Related]
55. Superimposed linear psoriasis: low effectiveness of biologic therapy.
Colombo L; Marconi M; Mapelli ET; Crespi E; Gualandri L; Menni S; Cerri A
G Ital Dermatol Venereol; 2011 Aug; 146(4):311-3. PubMed ID: 21785401
[No Abstract] [Full Text] [Related]
56. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Stiefelhagen P
MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277
[No Abstract] [Full Text] [Related]
57. Fumaric acid esters in the treatment of psoriasis.
Anstey AV
Br J Dermatol; 2010 Feb; 162(2):237-8. PubMed ID: 20374246
[No Abstract] [Full Text] [Related]
58. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby M
Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
[No Abstract] [Full Text] [Related]
59. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
[TBL] [Abstract][Full Text] [Related]
60. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care.
Gillard SE; Finlay AY
Int J Clin Pract; 2005 Nov; 59(11):1260-7. PubMed ID: 16236077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
